Ignite Creation Date:
2024-10-26 @ 3:39 PM
Last Modification Date:
2024-10-26 @ 3:39 PM
Study NCT ID:
NCT06576635
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-08-26
Brief Title:
LUNG-05 Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer NSCLC Metastatic Patients
Sponsor:
None
Organization:
None
Study Overview
Official Title:
LUNG-05 Investigating Chemotherapy Effectiveness for NSCLC Metastatic Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
LUNG-05
Brief Summary:
This is a Single arm Simons two stage pilot study in which patients with Non-Small Cell Lung Cancer NSCLC with metastatic disease 2L and beyond will receive OncoChoice-informed chemotherapy following National Cancer Care Network NCCN treatment guidelines on dosage and scheduling for NSCLC FDA approved drugs
Detailed Description:
This is a Single arm Simons two stage pilot study in which patients with Non-Small Cell Lung Cancer NSCLC with metastatic disease 2L and beyond will receive OncoChoice-informed chemotherapy following National Cancer Care Network NCCN treatment guidelines on dosage and scheduling for NSCLC FDA-approved drugs After confirmation of patient eligibility and patient consent receival patients will undergo biopsy andor removal of malignant fluids paracentesis thoracentesis PleurX catheter as part of standard of care procedures Biosamples will be shared in a timely fashion within 24 hr post collection with study sponsors OncoOptima to test drug responsiveness Participants will undergo additional testing as deemed necessary by the treating provider Any additional treatments will be at the discretion of the treating provider
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None